Related Experiment Videos
Modulation of a systemic Semliki Forest virus infection in mice by defective interfering virus
Abstract:
Evidence is presented that defective interfering (DI) Semliki Forest virus (SFV) can modulate the systemic infection in mice initiated by intraperitoneal inoculation of 10 LD50 SFV. Either the mean time of death was delayed or mice failed completely to develop any sign of disease. This prophylactic activity of DI virus was not due to the stimulation of an adaptive immune response since an equivalent amount of noninfectious virus antigen did not change the course of disease.
Insights
Defective interfering Semliki Forest virus (SFV) can protect mice from lethal SFV infection. This protective effect is not mediated by stimulating an adaptive immune response, suggesting a direct antiviral mechanism.
Area of Science:
- Virology
- Immunology
- Infectious Diseases
Background:
- Semliki Forest virus (SFV) causes systemic infections in mice.
- Defective interfering (DI) viruses are variants of standard viruses that require a helper virus for replication.
- DI viruses have been investigated for their potential to interfere with standard virus infections.
Purpose of the Study:
- To investigate the prophylactic activity of DI Semliki Forest virus (SFV) against systemic SFV infection in mice.
- To determine if the observed protective effect is mediated by an adaptive immune response.
Main Methods:
- Mice were inoculated intraperitoneally with a lethal dose (10 LD50) of SFV.
- Mice were co-administered with varying amounts of DI SFV.
- Control groups received noninfectious virus antigen instead of DI SFV.
- Survival rates and disease progression were monitored.
Main Results:
- Administration of DI SFV significantly delayed the mean time of death in mice infected with SFV.
- A proportion of mice treated with DI SFV showed no signs of disease, indicating complete protection.
- Noninfectious virus antigen did not alter the course of SFV infection, ruling out a simple antigen-specific immune stimulation.
Conclusions:
- Defective interfering SFV exhibits significant prophylactic activity against systemic SFV infection in mice.
- The protective mechanism of DI SFV does not rely on the induction of an adaptive immune response.
- DI SFV may offer a novel therapeutic strategy for viral infections, potentially through mechanisms other than adaptive immunity.